CiPPPA membership

Driving effective change through collective action

With the support of key industry players, CiPPPA members can drive effective change through collective action. All CiPPPA members join the partnership as an alliance member and take part in at least one Action Task Force.

1. Alliance members

The Alliance fosters collaboration and innovation by bringing together otherwise competing firms in a pre-competitive environment. By aligning themselves and pooling resources, the member organisations create a platform to address global environmental concerns, particularly related to the end-of-life management of pharmaceutical packaging.

2. CiPPPA Action Task Forces

Each CiPPPA Task Force is led by industry experts through organisational schemes and industry collaboration to develop and deploy solutions. These Task Forces play a crucial role in leveraging the expertise and resources of member organisations.

Alliance members

CiPPPA’s Alliance members foster collaboration and innovation and play an essential role in shaping the initiative’s impact and influence.

Action Task Force members

Our Action Task Force members serve as the drivers of CiPPPA’s initiatives and the take-back schemes being planned. The Task Forces are collaborative and cooperate across functions.

Blisters:

- AbbVie
- Honeywell
- Reckitt
- UCB
- Haleon
- Syensqo

Injectables:

- AbbVie
- Takeda
- UCB

Inhalers:

- Honeywell

Technical advisory members

The Technical Advisory Group advises the CiPPPA leadership and Task Forces on activities.

Steering Committee members

Steering Committee members are part of CiPPPA’s leadership and also participate in Action Task Forces. They provide organisational oversight, work with the technical advisors, and are supported by the Project Management Office (TDi Sustainability). Committee members tend to be from the following types of organisations:

1.
Pharmaceutical,
healthcare, and
veterinary
companies
2.
Packaging
suppliers and
manufacturers for
pharmaceuticals
3.
Contract Research
Organisations
(CROs)
4.
Research and
development
organisations in the
pharmaceutical
sector
5.
Clinical research
and testing
laboratories
Eligibility

CiPPPA is open to all organisations in the Primary Pharmaceutical Packaging (PPP) value chain. Pioneers who want to join the CiPPPA initiative must commit to the following:

Commitment
One:

Must join CiPPPA as an Alliance Member and contribute in accordance to business model and activities

Commitment
Two:

Contribute knowledge and/or financially depending on stakeholder grouping

Commitment
Three:

Must be signed up to at least one solution / Action Task Force

“By founding and establishing CiPPPA, we can deliver enhanced end-of-life for blister packs and related pharmaceutical packaging such as metered dose inhalers and injectables. The willingness of leading pharmaceutical companies and global OTC brands to support the initiative has been tremendous, and as CiPPPA continues to grow, so too does our ability to influence societal and cross-industry change.”

Duncan Flack
Global Sustainability Lead at Honeywell and Chairman of CiPPPA
“CiPPPA envisions a future where collective efforts shape our actions. We are building a pre-competitive platform where we draw inspiration from member initiatives, schemes, projects and current solutions and adapt collectively as an industry with a shared problem. The impact of what we achieve together is dependent on our actions today. CiPPPA is not just about recycling, repurposing and end-of-life removal of PPP from landfills; it’s about creating a positive, environmentally-conscious and enduring legacy for the benefit of all.”

Maryam Babba
TDi’s Multi-stakeholder Manager and Lead Project Manager for CiPPPA

Project Management Office

TDi Sustainability is the Project Management Office for CiPPPA – coordinating and supporting the initiative.

Interested in joining CiPPPA?

Join CiPPPA members in driving effective change through collective action.

Lets talk!